Trials / Withdrawn
WithdrawnNCT00573599
Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- United States Naval Medical Center, Portsmouth · Federal
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is improvement in pain scales between the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prochlorperazine and benadryl IV | prochlorperazine and benadryl IV, saline subQ |
| DRUG | Imitrex SubQ, saline IV | Imitrex SubQ, saline IV |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2007-12-14
- Last updated
- 2025-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00573599. Inclusion in this directory is not an endorsement.